e-learning
resources
Madrid 2019
Monday, 30.09.2019
Clinical and translational studies of bronchiectasis and non-TB mycobacterial infection
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Outcome of shorter treatment after culture conversion in non-cavitary MAC lung disease
Y. Park (Seoul, Republic of Korea), O. Kim (Seoul, Republic of Korea), B. Kwon (Seoul, Republic of Korea), T. Shim (Seoul, Republic of Korea), Y. Chong (Seoul, Republic of Korea), K. Jo (Seoul, Republic of Korea)
Source:
International Congress 2019 – Clinical and translational studies of bronchiectasis and non-TB mycobacterial infection
Session:
Clinical and translational studies of bronchiectasis and non-TB mycobacterial infection
Session type:
Poster Discussion
Number:
2160
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Y. Park (Seoul, Republic of Korea), O. Kim (Seoul, Republic of Korea), B. Kwon (Seoul, Republic of Korea), T. Shim (Seoul, Republic of Korea), Y. Chong (Seoul, Republic of Korea), K. Jo (Seoul, Republic of Korea). Outcome of shorter treatment after culture conversion in non-cavitary MAC lung disease. 2160
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Clinical utility of serum anti-mycobacterium avium complex (MAC) antibody for diagnosis of MAC lung disease in asymptomatic patients with radiologically suspected MAC lung disease: A pilot study
Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical and functional characterisation
Year: 2015
The value of semi-quantitative mycobacterial cultures for predicting culture conversion during MAC lung disease therapy
Source: International Congress 2014 – Interventions and other therapeutic approaches in respiratory infections
Year: 2014
Impact of atelectasis on survival in emphysema patients treated with bronchoscopic lung volume reduction
Source: Annual Congress 2013 –Bronchoscopic treatment of COPD and asthma: where are we going?
Year: 2013
Short term outcome of patients with advanced bronchiectasis and healed pulmonary tuberculosis from ICU
Source: Annual Congress 2008 - Acute lung injury and weaning
Year: 2008
Outcomes of patients undergoing treatment for non-tuberculous mycobacteria lung disease
Source: International Congress 2019 – Clinical investigations of non-TB mycobacterial infection
Year: 2019
Predicted versus observed respiratory parameters after lung resection in different postoperative periods in pulmonary tuberculosis patients
Source: International Congress 2019 – General thoracic surgery
Year: 2019
Factors associated with sputum culture conversion in patients with pulmonary tuberculosis
Source: International Congress 2017 – TB: co-morbidities and outcome
Year: 2017
Estimated postoperative pulmonary function and 6 months recovery for lobectomized lung cancer patients with and without COPD
Source: International Congress 2016 – Surgical strategy for complex diseases
Year: 2016
Predictors of delayed sputum culture conversion in tuberculosis patients
Source: Annual Congress 2011 - Clinical tuberculosis
Year: 2011
Long-term lung function follow-up in patients diagnosed and treated for pulmonary tuberculosis
Source: Annual Congress 2010 - Prognosis of tuberculosis
Year: 2010
Analysis of clinical course after pulmonary resection for
mycobacterium avium
complex lung disease in our hospital
Source: International Congress 2014 – Infection, thoracic trauma and congenital lesions
Year: 2014
Therapeutic outcomes for cavitary
Mycobacterium avium
complex (MAC) lung disease
Source: Annual Congress 2012 - Anti-infective treatment and resistance in respiratory infections
Year: 2012
Investigation burden in patients with fibrotic interstitial lung disease in their terminal admission
Source: International Congress 2018 – Management of idiopathic interstitial pneumonias: established and new treatments
Year: 2018
Mortality causes in patients with advanced lung disease in long term oxygen therapy
Source: International Congress 2018 – Integrated care and non-pharmacological management of COPD
Year: 2018
Diagnosis of latent tuberculosis infection in patients with chronic liver disease undergoing liver transplantation: performance of the new IFN-γ-based assays
Source: Eur Respir J 2007; 30: Suppl. 51, 752s
Year: 2007
Clinical characteristics and treatment outcomes of patients with pulmonary tuberculosis with delayed conversion over 4 months
Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes
Year: 2015
Lung function indices versus symptoms for monitoring the course of the disease in patients with COPD
Source: Annual Congress 2008 - Functionality and metabolism in rehabilitation candidates
Year: 2008
Pulmonary disease caused by M. malmoense in HIV negative patients: 5-yr follow-up of patients receiving standardised treatment
Source: Eur Respir J 2003; 21: 478-482
Year: 2003
Pitfalls in the registration and delay in the treatment of patients with culture positive pulmonary tuberculosis (CPPTB)
Source: Annual Congress 2007 - New methods to diagnose tuberculosis infection and disease and problems in tuberculosis care
Year: 2007
Effects of pulmonary rehabilitation in patients with severe COPD in comparison to patients with severe interstitial lung disease
Source: Annual Congress 2013 –The best posters in pulmonary rehabilitation
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept